Dr. Yuming Wang 王玉名
Chief Physician
Department of Bone and Soft Tissue Tumors, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of osteosarcoma, soft tissue sarcoma, melanoma, and bone metastases. Specializes in isolated limb perfusion chemotherapy, drug sensitivity testing, radiofrequency ablation, and needle biopsy for bone and soft tissue sarcomas.
Dr. Wang holds a Master of Surgery from China Medical University (2008) and graduated from Dalian Medical University (2000). The doctor has long focused on bone and soft tissue tumors. Dr. Wang has published three SCI-indexed papers and over ten national or provincial papers, led four Liaoning provincial projects, and received two Liaoning science and technology awards.
Professional roles
- Expert, Liaoning 12320 Health Hotline
Name order: in Chinese the family name comes first (Wang Yuming). Papers usually list the name as Yuming Wang or Wang Y.
Selected publications
12 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2025 (senior author): Exo-nanomaterials in cancer immunotherapy: reprogramming the tumor immune microenvironment. PubMed 41635841
- Life Sci, 2020 (first author): Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway. PubMed 32553931
- Biomed Pharmacother, 2017 (first author): SPOCK1 promotes the growth of Osteosarcoma cells through mTOR-S6K signaling pathway. PubMed 28869894
- Int J Clin Exp Pathol, 2017 (first author): Osteosarcoma cells induce differentiation of mesenchymal stem cells into cancer associated fibroblasts through Notch and Akt signaling pathway. PubMed 31966700
- Saudi J Biol Sci, 2017 (first author): Protection of oxidative stress induced apoptosis in osteosarcoma cells by dihydromyricetin through down-regulation of caspase activation and up-regulation of BcL-2. PubMed 28490955
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion